NeoGenomics Current Ratio 2006-2021 | NEO

Current and historical current ratio for NeoGenomics (NEO) from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. NeoGenomics current ratio for the three months ending June 30, 2021 was 7.28.
NeoGenomics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.72B $0.10B 7.28
2021-03-31 $0.94B $0.07B 13.92
2020-12-31 $0.45B $0.07B 6.13
2020-09-30 $0.42B $0.07B 6.54
2020-06-30 $0.42B $0.06B 6.79
2020-03-31 $0.22B $0.07B 3.19
2019-12-31 $0.29B $0.06B 4.55
2019-09-30 $0.29B $0.07B 4.24
2019-06-30 $0.28B $0.06B 4.67
2019-03-31 $0.12B $0.07B 1.60
2018-12-31 $0.10B $0.06B 1.70
2018-09-30 $0.19B $0.05B 4.13
2018-06-30 $0.08B $0.05B 1.74
2018-03-31 $0.09B $0.04B 2.03
2017-12-31 $0.09B $0.04B 2.36
2017-09-30 $0.09B $0.04B 2.14
2017-06-30 $0.08B $0.04B 2.37
2017-03-31 $0.09B $0.04B 2.12
2016-12-31 $0.08B $0.04B 2.07
2016-09-30 $0.09B $0.04B 2.62
2016-06-30 $0.09B $0.04B 2.50
2016-03-31 $0.08B $0.03B 2.37
2015-12-31 $0.08B $0.04B 2.06
2015-09-30 $0.06B $0.02B 3.97
2015-06-30 $0.06B $0.02B 3.94
2015-03-31 $0.06B $0.01B 4.14
2014-12-31 $0.06B $0.02B 4.02
2014-09-30 $0.06B $0.01B 4.10
2014-06-30 $0.03B $0.02B 1.84
2014-03-31 $0.03B $0.02B 1.85
2013-12-31 $0.03B $0.01B 1.92
2013-09-30 $0.02B $0.01B 1.95
2013-06-30 $0.02B $0.01B 1.92
2013-03-31 $0.02B $0.01B 1.90
2012-12-31 $0.02B $0.02B 1.05
2012-09-30 $0.02B $0.02B 1.03
2012-06-30 $0.02B $0.02B 1.10
2012-03-31 $0.02B $0.02B 1.08
2011-12-31 $0.01B $0.01B 1.15
2011-09-30 $0.01B $0.01B 1.17
2011-06-30 $0.01B $0.01B 1.19
2011-03-31 $0.01B $0.01B 1.22
2010-12-31 $0.01B $0.01B 0.95
2010-09-30 $0.01B $0.01B 0.97
2010-06-30 $0.01B $0.01B 1.08
2010-03-31 $0.01B $0.01B 1.24
2009-12-31 $0.01B $0.01B 1.48
2009-09-30 $0.01B $0.00B 2.01
2009-06-30 $0.01B $0.01B 1.11
2009-03-31 $0.01B $0.01B 1.14
2008-12-31 $0.00B $0.00B 0.99
2008-09-30 $0.01B $0.00B 1.17
2008-06-30 $0.01B $0.00B 1.16
2008-03-31 $0.00B $0.00B 1.24
2007-12-31 $0.00B $0.00B 1.24
2007-09-30 $0.00B $0.00B 2.46
2007-06-30 $0.00B $0.00B 2.87
2007-03-31 $0.00B $0.00B 0.98
2006-12-31 $0.00B $0.00B 0.72
2006-09-30 $0.00B $0.00B 2.21
2006-06-30 $0.00B $0.00B 1.86
2006-03-31 $0.00B $0.00B 1.68
2005-12-31 $0.00B $0.00B 1.02
2005-09-30 $0.00B $0.00B 1.24
2005-06-30 $0.00B $0.00B 1.35
2005-03-31 $0.00B $0.00B 1.09
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.163B $0.444B
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71